Discover
BIAF
bioAffinity Technologies, Inc.
0.84
2 x 0.58
2 x 1.07
bid
ask
+
0.03
3.88%
2 @ 05:15 AM
0.83 -0.02 (1.79%)
| Ytd | -28.52% | |
| 1y | -89.35% |
0.81
day range
0.85
0.69
52 week range
13.50
| Open | 0.84 | Prev Close | 0.81 | Low | 0.81 | High | 0.85 | Mkt Cap | 5.30M |
| Vol | 485.91K | Avg Vol | 465.42K | EPS | -4.67 | P/E | N/A | Forward P/E | -1.58 |
| Beta | 3.12 | Short Ratio | 1.43 | Inst. Own | 3.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 1.67 | 200-d Avg | 2.08 | 1yr Est | 6.00 |
| Income Statement | |||
| Total Revenue | 1.35M | ||
| Revenues (USD) | 1.35M | ||
| Cost of Revenue | 928.64K | ||
| Gross Profit | 422.89K | ||
| Operating Expenses | 4.04M | ||
| Research and Development Expense | 349.71K | ||
| Selling, General and Administrative Expense | 3.24M | ||
| Operating Income | -3.62M | ||
| Interest Expense | 14.72K | ||
| Net Income | -3.63M | ||
| Net Income Common Stock | -3.63M | ||
| Net Income Common Stock (USD) | -3.63M | ||
| Consolidated Income | -3.63M | ||
| Earnings per Basic Share | -0.81 | ||
| Earnings per Basic Share (USD) | -0.81 | ||
| Earnings per Diluted Share | -0.81 | ||
| Earning Before Interest & Taxes (EBIT) | -3.62M | ||
| Earning Before Interest & Taxes (USD) | -3.62M | ||
| Weighted Average Shares | 4.49M | ||
| Weighted Average Shares Diluted | 4.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.10M | ||
| Cash and Equivalents (USD) | 3.10M | ||
| Trade and Non-Trade Receivables | 685.24K | ||
| Current Assets | 4.34M | ||
| Property, Plant & Equipment Net | 1.48M | ||
| Total Assets | 7.95M | ||
| Debt Current | 283.69K | ||
| Total Debt | 1.38M | ||
| Current Liabilities | 3.18M | ||
| Debt Non-Current | 1.10M | ||
| Total Liabilities | 4.28M | ||
| Accumulated Retained Earnings (Deficit) | -72.18M | ||
| Shareholders Equity | 3.66M | ||
| Shareholders Equity (USD) | 3.66M | ||
| Assets Non-Current | 3.60M | ||
| Total Debt (USD) | 1.38M | ||
| Deferred Revenue | 31.14K | ||
| Goodwill and Intangible Assets | 2.11M | ||
| Inventory | 77.89K | ||
| Liabilities Non-Current | 1.10M | ||
| Trade and Non-Trade Payables | 836.21K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 114.52K | ||
| Net Cash Flow from Financing | -118.51K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.35M | ||
| Capital Expenditure | -5.66K | ||
| Issuance (Repayment) of Debt Securities | -118.51K | ||
| Net Cash Flow from Investing | -5.66K | ||
| Net Cash Flow from Operations | -3.23M | ||
| Share Based Compensation | 14.34K | ||